

| Dosage | Package | Price per Dose | Price | |
|---|---|---|---|---|
| 40mg | 360 pills | A$1.24 | A$596.84 A$447.63 Popular | |
| 40mg | 180 pills | A$1.29 | A$307.27 A$230.45 | |
| 40mg | 120 pills | A$1.35 | A$215.67 A$161.75 | |
| 40mg | 90 pills | A$1.42 | A$171.35 A$128.51 | |
| 40mg | 60 pills | A$1.55 | A$124.07 A$93.05 | |
| 40mg | 30 pills | A$1.84 | A$73.84 A$55.38 | |
| 80mg | 360 pills | A$1.20 | A$573.20 A$429.90 Best Price | |
| 80mg | 180 pills | A$1.26 | A$304.31 A$228.24 | |
| 80mg | 120 pills | A$1.37 | A$218.63 A$163.97 | |
| 80mg | 90 pills | A$1.46 | A$174.30 A$130.73 | |
| 80mg | 60 pills | A$1.57 | A$127.03 A$95.27 | |
| 80mg | 30 pills | A$1.66 | A$67.93 A$50.95 | |
| 120mg | 90 pills | A$1.64 | A$197.94 A$148.46 | |
| 120mg | 60 pills | A$1.71 | A$135.89 A$101.92 | |
| 120mg | 30 pills | A$1.97 | A$79.75 A$59.81 | |
| 240mg | 90 pills | A$2.93 | A$351.59 A$263.69 | |
| 240mg | 60 pills | A$3.21 | A$257.04 A$192.78 | |
| 240mg | 30 pills | A$4.14 | A$165.44 A$124.08 |
Disclaimer: This information is for adults in Australia and is not a substitute for professional medical advice. Seek personalised guidance from a clinician or pharmacist for individual circumstances.
Calcium channel blockers are among the most commonly prescribed medicines for high blood pressure and chest pain management (angina). They work by relaxing the smooth muscle in the walls of arteries, which widens the vessels and lowers blood pressure while reducing the heart's workload.
Calan is the brand name for verapamil hydrochloride, a medication in this class. Verapamil is available in several formulations that differ in how quickly the drug is released into the body. The choice of formulation influences how often it is taken and the length of action.
Verapamil acts on calcium channels in the heart and blood vessels, decreasing the force of the heart's contractions and slowing the conduction of electrical impulses through the atrioventricular (AV) node. This can relieve chest pain and help regulate heart rhythm in some arrhythmias.
The medicine may be prescribed by a clinician after a medical assessment, taking into account other medicines, existing health conditions, and potential drug interactions. In Australia, this medication may require a prescription depending on local rules and the specific formulation selected.
During use, regular monitoring of blood pressure and heart rate is commonly advised, and adjustments to the dose may be made to achieve the desired therapeutic effect while minimising adverse effects.
Calan is used to treat several cardiovascular conditions in adults. Its effect on the arteries can help reduce chest pain caused by angina and lower elevated blood pressure. Verapamil may also be prescribed for certain fast heart rhythms that originate above the ventricles (supraventricular tachycardias) when other treatments are not suitable.
For some individuals, Calan can be effective in preventing episodes of chest pain by improving blood flow to the heart muscle. The medication may decrease the heart’s workload, which can contribute to more stable daily functioning and better exercise tolerance in suitable patients.
In Australia, the decision to start Calan is based on a thorough clinical assessment. Consideration is given to kidney or liver function, current medications, and any history of heart block or heart failure with reduced ejection fraction. The choice of product form and dosing frequency is tailored to the individual.
Verapamil may be used as part of a broader treatment plan that includes lifestyle measures such as regular physical activity, a heart-healthy diet, and smoking cessation where applicable. It is not a substitute for these measures, but an adjunct that supports symptom control and blood pressure management.
All indications are subject to clinical judgement and local regulatory rules. If uncertainty exists about the suitability of Calan for a specific condition, consultation with a clinician or pharmacist is advised.
Before commencing therapy, a clinician will review medical history, current medications, and potential drug interactions. A physical assessment will commonly include blood pressure and heart rate measurements, and sometimes an electrocardiogram (ECG) or laboratory tests. The goal is to select a safe starting dose and an appropriate escalation plan.
Step 1: Confirm prescription and baseline checks. The suitability of Calan is confirmed by a clinician, who will consider all health conditions. A comprehensive medication list will be reviewed to identify possible interactions with other prescribed medicines or over-the-counter products.
Step 2: Dose selection and titration. A low starting dose is often chosen to assess tolerance, with gradual increases as needed and as advised by a clinician. Treatment goals are balancing symptom control with the minimisation of side effects. Patient response is monitored through blood pressure, heart rate, and symptom reporting.
Step 3: Filling and storage considerations. When a prescription is filled, the exact product name and formulation should be confirmed. Instructions on storage, handling, and any special administration requirements will be provided by the pharmacist. The medicine should be kept in its original packaging until use and out of reach of children.
Step 4: Initial period and safety checks. The initial days to weeks often involve close monitoring for lightheadedness, dizziness, or flushing as the body adjusts. Any concerning symptoms should be reported to a clinician promptly. A plan for follow-up visits or communication is typically arranged by the prescribing clinician.
Calan can be taken with or without food, depending on the formulation and the clinician’s guidance. Consistency in timing helps maintain steady drug levels and symptom control. The chosen dosing schedule is intended to be easy to follow and compatible with daily routines.
With respect to meals, some formulations may be more compatible with food intake than others. Continued adherence to the chosen pattern is recommended unless advised otherwise by a clinician. It is important not to alter dosing timing or frequency without professional input.
Missed doses should be handled according to a clinician’s instructions. In general, if a dose is missed, do not double the next dose to make up for it unless explicitly advised. Instead, resume the regular schedule and contact a pharmacist or clinician if there is any uncertainty.
For patients who experience dizziness or lightheadedness upon standing during dose initiation, changing position slowly can help reduce symptoms. If lightheadedness is persistent or severe, medical advice should be sought so adjustments can be made safely.
Alcohol consumption and certain other medicines may interact with Calan, potentially affecting blood pressure or heart rate. Before combining with alcohol or new medicines, a clinician or pharmacist should be consulted to assess risks and plan appropriately.
Within a few days of starting treatment, reductions in chest pain episodes or improved exercise tolerance may be noticed, depending on the condition being treated. Blood pressure changes also begin to appear as the body responds to the medication.
During the initial period, some individuals may experience dizziness, flushing, or heart rhythm changes, particularly when standing up or during physical activity. These effects often improve with time as the body adjusts or with dose adjustments under professional supervision.
Constipation is a known effect associated with verapamil; adequate hydration and, if advised, dietary adjustments may help. Severe or persistent symptoms should be discussed with a clinician to determine whether management strategies or dose modifications are needed.
Monitoring is typically ongoing through routine clinic visits or telehealth check-ins. Adjustments to therapy are made only under medical supervision to maintain symptom control while minimising adverse effects.
Any new medicines or changes to existing medications should be reported promptly. Interactions may alter the effectiveness of Calan or increase the risk of side effects, necessitating a clinical review.
Calan is not suitable for everyone. Cautions apply in the presence of certain conditions, such as significant heart block, severe heart failure with reduced ejection fraction, or symptomatic hypotension. A history of bradycardia (slow heart rate) or ventricular dysfunction requires careful assessment before use.
Potential drug interactions are an important consideration. Verapamil can interact with certain heart rhythm medicines, blood pressure medicines, antifungal agents, macrolide antibiotics, and various herbal or over-the-counter products. A full medication list should be reviewed with a clinician or pharmacist to identify any high-risk combinations.
Pregnant or breastfeeding individuals should consult a clinician regarding the safety of Calan. The balance of benefits and risks must be discussed, and alternatives may be considered if applicable.
Symptoms that warrant urgent medical attention include signs of severe dizziness, fainting, very slow heart rate, persistent chest pain, swelling of limbs, or signs of an allergic reaction. Seek urgent medical help if such symptoms occur.
Avoid sudden discontinuation of Calan without professional guidance. Stopping abruptly may cause adverse cardiovascular effects, especially in individuals with hypertension or certain arrhythmias. A clinician will provide a plan for safe withdrawal if needed.
Store Calan at room temperature, away from heat, moisture, and direct light. Keep the medication in its original packaging until use, and replace the container cap securely after each access. Do not transfer tablets to another container, which could affect stability or dosing accuracy.
Keep all medicines out of reach of children and pets. Do not share prescription medicines with others, even if symptoms appear similar. When the medicine is no longer required or has expired, disposal should follow local guidelines or pharmacy take-back programs where available.
Do not use Calan beyond the expiry date displayed on the package. If any tablets appear damaged, discoloured, or compromised, consult a pharmacist for safe disposal guidance and replacement options.
Travel often requires extra planning to ensure uninterrupted therapy. Carry sufficient supply, keep medicine in original packaging, and bring a copy of the prescription or a letter from the clinician if crossing borders. Medication during air travel should be stored as advised by the airline and security authorities.
Dental work or anesthesia administration may interact with Calan, particularly if other heart or blood pressure medications are used. Inform the dentist or medical team about all current medicines to ensure appropriate management during procedures. Additional monitoring or temporary adjustments may be advised.
If a dose is accidentally missed, follow the clinician’s guidance. Do not double-dose unless explicitly instructed. If there is uncertainty, contact a pharmacist or clinician for advice before the next dose is due.
Switching from another calcium channel blocker or another antianginal agent is possible under medical supervision. A gradual transition plan is often chosen to minimise overlapping effects and reduce the risk of adverse symptoms during the switch.
Storage considerations remain the same during travel, including protection from heat and moisture and staying within specified temperatures. Always keep a current list of medicines available for reference in case of emergencies or medical consultations.
Several adverse effects may occur with Calan, especially during the initial weeks. Common experiences include headaches, flushing, dizziness, or lightheadedness, particularly when rising from a seated or lying position. These effects often ease with time or with dose adjustments.
Constipation is frequently reported and should be managed with hydration and dietary fibre as advised by a clinician. If constipation becomes persistent or painful, medical advice should be sought to explore supportive measures or dose modification.
Swelling in the ankles or feet, a faster or irregular heartbeat, or shortness of breath may indicate a more significant reaction or an underlying condition. If such symptoms occur, contact a clinician promptly for assessment and guidance.
Allergic reactions, though uncommon, require urgent medical attention. Signs may include swelling of the face or throat, severe rash, or difficulty breathing. Seek immediate help if these occur.
Patients should avoid abrupt discontinuation of Calan. If withdrawal is needed, it should be conducted under professional supervision, with a plan to monitor for return of symptoms or blood pressure fluctuations.
The following questions address practical situations encountered in everyday life. For each question, the answer provides cautious guidance and emphasizes consulting a clinician for personalised advice.
Can Calan be used while travelling or during long trips? The medicine can be taken while travelling, but attention should be given to keeping a steady supply, maintaining the prescribed dosing schedule, and staying hydrated. It may be helpful to carry a copy of the prescription and a note from the clinician about the purpose of the medicine.
Is it safe to take Calan at the same time as common over-the-counter pain relievers or cold medicines? Interactions are possible with some non-prescription products. A clinician or pharmacist should be consulted to assess the safety of combining Calan with NSAIDs, decongestants, or other non-prescription agents.
What happens if the medication is taken at the wrong time or with food? A delay or variation in timing can affect blood pressure control or heart rate. If a dose is consistently missed or taken inconsistently, a clinician should be informed to determine whether adjustments are needed.
Can Calan be switched from a different calcium channel blocker or another antianginal? Switching is sometimes appropriate and must be performed under medical supervision. A gradual transition plan may be used to minimise symptoms and adverse effects during the change.
How long will it take to notice an improvement in chest pain or blood pressure after starting Calan? Individual responses vary. Some patients may experience improvement within days, while others may take weeks. The clinician will monitor progress and adjust therapy as needed.
Can Calan be split or crushed? This depends on the formulation. Some products should not be crushed or split, particularly extended-release forms. The pharmacist will provide specific guidance based on the product being dispensed.
What should be discussed with a dentist or during dental procedures? Verapamil can interact with certain drugs used during dental care or anesthesia. It is important to inform the dentist about all current medicines so that appropriate precautions can be taken.
Is Calan safe for older adults? In older individuals, a careful assessment of kidney and liver function, as well as monitoring for dizziness or falls, is common. Dosing may be adjusted to minimise adverse effects while preserving therapeutic benefit.
What should be done if severe side effects occur? Severe symptoms, such as fainting, chest pain, or signs of an allergic reaction, require urgent medical attention. Do not delay seeking help if such symptoms develop.
Can Calan interact with alcohol? Alcohol may influence blood pressure and heart rate, and interactions with Calan could increase dizziness or hypotension. It is prudent to limit or avoid alcohol and discuss consumption with a clinician.
Should Calan be used during pregnancy or breastfeeding? The safety profile requires careful evaluation of benefits and risks. A clinician will discuss options and alternatives if pregnancy or breastfeeding is planned or suspected.
What about disposing of unused tablets? Do not keep unused medication beyond its expiry date. Follow local disposal guidelines or ask a pharmacist about take-back programs to ensure safe disposal.
Will Calan affect medical tests or devices, such as an implanted pacemaker? Some interactions with heart devices are possible. It is important to inform the healthcare team about all medicines being taken prior to any diagnostic tests or device procedures.
What should be done if a dose is missed during a hospital stay or during a change in healthcare providers? Clear communication with the treating team is essential. A plan documenting dose timing and any necessary adjustments should be established to maintain consistent therapy.
Is it possible to obtain Calan without a prescription, or does it require a formal prescription in Australia? Availability may depend on local rules and the specific product. Consultation with a clinician or pharmacist is advised to confirm the appropriate pathway for access.
14–21 days. Free from A$285.95 .
5–9 days. A$42.89
−10% when paying with cryptocurrency.
−10% on all repeat orders.
All orders are packed in neutral, unbranded boxes with no product name on the outside.
